Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction
- PMID: 39585932
- PMCID: PMC11594480
- DOI: 10.1161/CIRCULATIONAHA.124.072172
Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction
Keywords: CaMKII; DAMP; Editorials; MACE; RIPK3; biomarkers; cell death; inflammation; myocardial infarction; necroptosis.
Conflict of interest statement
None.
Comment on
-
Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury.Circulation. 2024 Nov 26;150(22):1791-1811. doi: 10.1161/CIRCULATIONAHA.123.068595. Epub 2024 Oct 16. Circulation. 2024. PMID: 39411860
References
-
- Newton K, Strasser A, Kayagaki N and Dixit VM. Cell death. Cell. 2024;187:235–256. - PubMed
-
- Newton K, Dugger DL, Maltzman A, Greve JM, Hedehus M, Martin-McNulty B, Carano RA, Cao TC, van Bruggen N, Bernstein L, Lee WP, Wu X, DeVoss J, Zhang J, Jeet S, Peng I, McKenzie BS, Roose-Girma M, Caplazi P, Diehl L, Webster JD and Vucic D. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 2016;23:1565–76. - PMC - PubMed
-
- Zhang T, Zhang Y, Cui MY, Jin L, Wang YM, Lv FX, Liu YL, Zheng W, Shang HB, Zhang J, Zhang M, Wu HK, Guo JJ, Zhang XQ, Hu XL, Cao CM and Xiao RP. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22:175–182. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
